CIPLA LTD. (INDIA)
Viraday
"Viraday" contains three active ingredients, the "Antiretrovirals Efavirenz (600mg), Tenofovir Disoproxilfumarate (300mg) and Emtricitabine (200mg)" used to treat HIV infection. It prevent or slow down the ability of HIV to replicate and spread, which keeps the amount virus down to a low level and this results in an increase in CD4 cell numbers, so that the immune system can recover, reducing the risk of disease progression.
Indication
Viraday tablets are a fixed dose combination treatment for Human Immunodeficiency Virus (HIV) infection.
Note
Precaution
- Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, throat, or tongue).
Updated On Oct 17, 2019 by Admin
Strength
Efavirenz(600mg), Tenofovirdisoproxilfumarate(300mg), Emtricitabine(200mg).
Packing
1*30 Tablets (Bottle)
Storage
Store at room Temperature (25°C), away from heat, moisture, and light.
Was this page helpful?
Related Products
CIPLA LTD. (INDIA)
Viraday
NATCO PHARMA LIMITED (INDIA)
Natclovir
NATCO PHARMA LIMITED (INDIA)
Tafanat
NATCO PHARMA LIMITED (INDIA)
Ganciclovir-natclovir
Most Viewed Products
CIPLA LTD. (INDIA)
Abiraterone acetate-xbira
NATCO PHARMA LIMITED (INDIA)
Bendamustine-bendit
CIPLA LTD. (INDIA)
Bicalutamide-cassotide
NATCO PHARMA LIMITED (INDIA)
Bortezomib-bortenat
NATCO PHARMA LIMITED (INDIA)
Erlonat
Biocon Limited
Everolimus-evertor
NATCO PHARMA LIMITED (INDIA)
Exemestane-xtane
NATCO PHARMA LIMITED (INDIA)
Geftinat
NATCO PHARMA LIMITED (INDIA)
Glatiramer acetate-glatimer
NATCO PHARMA LIMITED (INDIA)
Ledipasvir & sofosbuvir-hepcinat lp
NATCO PHARMA LIMITED (INDIA)
Lenalidomide-lenalid
NATCO PHARMA LIMITED (INDIA)
Pomalidomide-pomalid
NATCO PHARMA LIMITED (INDIA)
Sofosbuvir & velpatasvir-velpanat
NATCO PHARMA LIMITED (INDIA)
Sorafenib-sorafenat
CIPLA LTD. (INDIA)